AR-08 is primarily utilized in research and development within the pharmaceutical industry, particularly in the study of neurodegenerative diseases. It has shown potential in modulating specific biological pathways that are critical in conditions like Alzheimer's and Parkinson's disease. Researchers are exploring its efficacy in reducing neuroinflammation and oxidative stress, which are key factors in the progression of these disorders. Additionally, AR-08 is being investigated for its role in enhancing cognitive function and protecting neuronal cells from damage. Its application extends to preclinical trials where it is used to assess safety, dosage, and therapeutic effects, paving the way for potential future treatments.